CV Therapeutics Statement on Unsolicited Proposal From Astellas

Wednesday 28th of January 2009 0:09

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

• CV Therapeutics Statement on Unsolicited Proposal From Astellas ... In light of an announcement made recently by Astellas Pharma Inc., CV Therapeutics, Inc. confirmed that it had received a letter dated November 13,
  ...
  http://www.drugs.com/news/cv-therapeutics-statement-unsolici...
  
  
• Archive News & Video for Wednesday, 28 Jan, 2009 | Reuters.com 28 Jan 2009 ... CV Therapeutics Statement on Unsolicited Proposal From Astellas 12:09 AM EST. Iceland's Straumur eyes move to London-FT 12:04 AM EST ...
  http://www.reuters.com/resources/archive/us/20090128.html...
  
  
• Drugs.com - Pharmaceutical Industry News Archive January 2009 January 28, CV Therapeutics Statement on Unsolicited Proposal From Astellas. January 28, Sequenom Terminates Exchange Offer to Acquire EXACT Sciences ...
  http://www.drugs.com/news-archive/January-2009.html...
  
  

Browse other news from this organisation: CV Therapeutics, Inc.

Related Web-Links

(If any, Generated Automatically)

• Japan's Astellas bids $3.5 billion for OSI Pharma - Yahoo! Finance
• News: Astellas Bids $3.5B on OSI for Cancer Focus.
• Biotechnology Industry News News Archive - Yahoo! Finance
• BioSpace offers Pharmaceutical, Biotechnology and Healthcare ...
• Drug-Induced Torsade de Pointes and Implications for Drug Development

Source: PR Newswire



www.prnewswire.co.uk

Browse news from 2009

Download PDF